Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Topical DRM02 in Atopic Dermatitis
NCT01993420Phase 2Completed
- Sponsor
- Dermira, Inc.
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of drm02 in atopic dermatitis (AD), sponsored by Dermira, Inc.. Started Oct 2013; status: completed.
02
Drugs
drm02
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01993420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993420.